Skip to content
★ Sign in to follow
NP

Norman Paul Klein II

Cellular Biomedicine Group, Inc.
Total declarations
24
Company
1
▲ Purchases (14 ops.)
€408k
▼ Sales (5 ops.)
€140k

Latest filing published 11 Feb 2011 for Cellular Biomedicine Group, Inc., €83k.

Insider track record

Disclosed buys
14
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
14

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Norman Paul Klein II: trading record in brief

Norman Paul Klein II appears in our data through filings on Cellular Biomedicine Group, Inc. shares, published by SEC (Form 4). In total, 24 filings cover trades dated from 28 December 2006 to 11 February 2011.

Both buying and selling appear: 14 purchases worth €408k, against 5 sales worth €140k. Taken together, the purchases exceed the sales by €268k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants. In 2011 alone, the filings show no purchases and 1 sale.

A typical purchase (the median) is worth €13k.

The latest filing, published on 11 February 2011, reports an open-market sale of €83k in Cellular Biomedicine Group, Inc. The last insider purchase was made public on 22 May 2009, 6,380 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Norman Paul Klein II

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations